ISSN 2097-6046(网络)
ISSN 2096-7446(印刷)
CN 10-1655/R
主管:中国科学技术协会
主办:中华护理学会
论著

胰腺癌根治术联合自体小肠移植患者出院后随访清单的构建及应用研究

  • 卢芳燕 ,
  • 吉莉 ,
  • 董丽 ,
  • 吴静韵 ,
  • 杨云 ,
  • 汤洒潇 ,
  • 王华芬
展开
  • 1.浙江大学医学院附属第一医院护理部 杭州市 310003
    2.浙江大学医学院附属第一医院肝胆胰外科 杭州市 310003
卢芳燕:女,硕士,主任护师,护理部常务副主任,E-mail:2196032@zju.edu.cn
*王华芬,E-mail:2185015@zju.edu.cn

收稿日期: 2025-05-05

  网络出版日期: 2026-01-06

Development and application of a follow-up checklist for postoperative patients of pancreatic cancer undergoing radical resection combined with intestinal autotransplantation

  • LU Fangyan ,
  • JI Li ,
  • DONG Li ,
  • WU Jingyun ,
  • YANG Yun ,
  • TANG Saxiao ,
  • WANG Huafen
Expand
  • 1. Nursing Departmentthe First Affiliated Hospital,Zhejiang University School of MedicineHangzhou 310003, China
    2. Department of Hepatobiliary and Pancreatic Surgerythe First Affiliated Hospital,Zhejiang University School of MedicineHangzhou 310003, China

Received date: 2025-05-05

  Online published: 2026-01-06

摘要

目的 制订胰腺癌根治术联合自体小肠移植患者出院后随访清单,为随访工作提供科学的工具支持,及时发现并解决患者出院后可能遇到的问题,确保远期疗效。方法 通过文献回顾拟订随访清单初稿。2024年9月,采用德尔菲法对14名专家进行2轮函询,综合专家意见并进行修订,形成随访清单终稿。2024年11月,采用便利抽样法,选取浙江省某三级甲等医院14例胰腺癌根治术联合自体小肠移植患者作为研究对象,随访护士采用该随访清单对患者进行电话随访,并对清单进行评价。结果 2轮函询问卷的有效回收率分别为93.33%和100%,专家权威系数分别为0.939、0.947,变异系数为0~0.167和0~0.141,肯德尔和谐系数为0.137和0.140(P<0.05)。最终形成的随访清单包含3项一级指标、12项二级指标及27项三级指标。护士和患者均认为该随访清单内容全面,具有较强的专科性和临床实用性。结论 构建的随访清单结构合理,内容详尽,专科性和实用性突出,能够为胰腺癌根治术联合自体小肠移植患者出院后的随访提供科学、规范的工具支持。

本文引用格式

卢芳燕 , 吉莉 , 董丽 , 吴静韵 , 杨云 , 汤洒潇 , 王华芬 . 胰腺癌根治术联合自体小肠移植患者出院后随访清单的构建及应用研究[J]. 中华急危重症护理杂志, 2026 , 7(1) : 9 -15 . DOI: 10.3761/j.issn.2096-7446.2026.01.001

Abstract

Objective To formulate a follow-up checklist for postoperative patients of pancreatic cancer undergoing radical resection combined with intestinal autotransplantation,and provide a scientific tool to support the follow-up work,timely identify and solve problems encountered by patients after discharge,and ensure the long-term efficacy. Methods The first draft of the follow-up checklist was constructed through literature review,and the final draft of the follow-up checklist was formed by conducting 2 rounds of correspondence with 14 experts using the Delphi method in September 2024,screening experts’ opinions and revising and improving the checklist. The convenience sampling method was adopted to select 14 postoperative patients of pancreatic cancer with radical resection combined with intestinal autotransplantation from a tertiary class A hospital in Zhejiang Province in November 2024 as the research subjects. The nurses conducted telephone follow-up to the patients with the postoperative follow-up list and evaluated the follow-up list. Results The effective response rates of 2 rounds of expert consultations were 93.33% and 100%,the authoritative coefficients were 0.939 and 0.947,the variation coefficients of each item ranged from 0 to 0.167 and from 0 to 0.141,and the Kendall harmony coefficient was 0.137 and 0.140(P<0.05). The final follow-up checklist included 3 primary indicators,12 secondary indicators and 27 tertiary indicators. Both nurses and patients believed that the follow-up checklist was comprehensive with strong professional and clinical practicability. Conclusion The follow-up checklist is reasonable in structure,comprehensive in content,specialized and practical,which can provide a scientific and standardized tool to support post-discharge follow-up of pancreatic cancer patients undergoing radical resection combined with intestinal autotransplantation.

参考文献

[1] Han BF, Zheng RS, Zeng HM, et al. Cancer incidence and mortality in China,2022[J]. J Natl Cancer Cent, 2024, 4(1):47-53.
[2] Liang TB, Zhang Q, Wu GS, et al. Radical resection combined with intestinal autotransplantation for locally advanced pancreatic cancer after neoadjuvant therapy:a report of 36 consecutive cases[J]. Ann Surg, 2023, 278(5):e1055-e1062.
[3] 梁廷波. 联合自体小肠移植的胰腺癌根治手术[M]. 北京: 人民卫生出版社, 2022:5.
  Liang TB. Radical resection combined with intestinal autotransplantation for pancreatic cancer[M]. Beijing: People’s Medical Publishing House, 2022:5.
[4] 张成东, 王莺, 卢芳燕. 32例胰腺癌根治手术联合自体小肠移植的护理配合[J]. 中华护理杂志, 2024, 59(16):2009-2013.
  Zhang CD, Wang Y, Lu FY. Nursing cooperation in 32 cases of pancreatic cancer undergoing radical surgery combined with intestinal autotransplantation[J]. Chin J Nurs, 2024, 59(16):2009-2013.
[5] 王群敏, 卢芳燕, 王飞霞, 等. 11例胰十二指肠切除联合自体小肠移植患者的围手术期护理[J]. 中华急危重症护理杂志, 2021, 2(5):432-435.
  Wang QM, Lu FY, Wang FX, et al. Perioperative nursing of 11 cases of pancreaticoduodenectomy combined with intestinal autotransplantation[J]. Chin J Emerg Crit Care Nurs, 2021, 2(5):432-435.
[6] Phillips ME, Hopper AD, Leeds JS, et al. Consensus for the management of pancreatic exocrine insufficiency:UK practical guidelines[J]. BMJ Open Gastroenterol, 2021, 8(1):e000643.
[7] Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer:ESMO clinical practice guideline for diagnosis,treatment and follow-up[J]. Ann Oncol, 2023, 34(11):987-1002.
[8] European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms[J]. Gut, 2018, 67(5):789-804.
[9] Hidalgo M, álvarez R, Gallego J, et al. Consensus guidelines for diagnosis,treatment and follow-up of patients with pancreatic cancer in Spain[J]. Clin Transl Oncol, 2017, 19(6):667-681.
[10] Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients[J]. Gastroenterology, 2006, 130(2Suppl 1): S43-S51.
[11] Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2. 2021,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19(4):439-457.
[12] 国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(5):1006-1030.
  General Office of National Health Commission. Standard for diagnosis and treatment of pancreatic cancer(2022 edition)[J]. J Clin Hepatol, 2022, 38(5):1006-1030.
[13] 袁丽, 张海玲, 乔晓斐, 等. 胰腺癌患者围手术期营养管理的最佳证据总结[J]. 中华现代护理杂志, 2024, 30(3):351-357.
  Yuan L, Zhang HL, Qiao XF, et al. Summary of the best evidence for perioperative nutrition management in patients with pancreatic cancer[J]. Chin J Mod Nurs, 2024, 30(3):351-357.
[14] 中华医学会外科学分会胰腺外科学组, 中华医学会肠外肠内营养学分会. 胰腺外科围术期全程化营养管理中国专家共识(2020版)[J]. 中华消化外科杂志, 2020, 19(10):1013-1029.
  Chinese Society of Pancreatic Surgery of Surgery Branch, Chinese Medical Association; Chinese Society of Parenteral and Enteral Nutrition,Chinese Medical Association. Chinese expert consensus on perioperative whole-course nutrition management for pancreatic surgery(2020 edition)[J]. Chin J Dig Sur, 2020, 19(10):1013-1029.
[15] Luo H, Galv?o DA, Newton RU, et al. Exercise medicine in the management of pancreatic cancer:a systematic review[J]. Pancreas, 2021, 50(3):280-292.
[16] Xu JY, Wang LJ, Li PX, et al. Perioperative and post-hospital whole-course nutrition management in patients with pancreatoduodenectomy:a single-center prospective randomized controlled trial[J]. Int J Surg, 2024, 110(7):4185-4196.
[17] Eggers C, Olliges E, Boeck S, et al. Exploring pain,quality of life,and emotional well-being in patients with advanced pancreatic cancer practicing spiritual meditation:a pilot study[J]. Complement Med Res, 2023, 30(4):289-298.
[18] Zhang C, Zironda A, Vierkant RA, et al. Quality of life and gastrointestinal symptoms in long-term survivors of pancreatic cancer following pancreatoduodenectomy[J]. Ann Surg, 2024, 279(5):842-849.
[19] 汤娟娟, 刘浩楠, 秦晓冰, 等. 盐酸安罗替尼联合化疗治疗晚期胰腺癌的临床分析[J]. 徐州医科大学学报, 2024, 44(6):404-408.
  Tang JJ, Liu HN, Qin XB, et al. Clinical analysis of anlotinib hydrochloride in combination with chemotherapy in the treatment of advanced pancreatic cancer[J]. J Xuzhou Med Univ, 2024, 44(6):404-408.
[20] Liu CY, Liu LL, Chen MX. Experience of living with symptom clusters in postoperative pancreatic cancer patients[J]. Eur J Oncol Nurs, 2023, 62:102266.
[21] Ristau P, Oetting-Ro? C, Büscher A. From surviving to living (on):a grounded theory study on coping in people with pancreatic cancer[J]. J Patient Exp, 2023, 10:23743735231215605.
[22] Mansournia MA, Collins GS, Nielsen RO, et al. A checklist for statistical assessment of medical papers(the CHAMP statement):explanation and elaboration[J]. Br J Sports Med, 2021, 55(18):1009-1017.
[23] Powell-Brett S, de Liguori Carino N, Roberts K. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer[J]. Eur J Surg Oncol, 2021, 47(3 Pt A):539-544.
[24] 蔡正华, 杨翼飞, 包善华, 等. 胰腺术后胰源性糖尿病研究进展[J]. 腹部外科, 2021, 34(5):396-399.
  Cai ZH, Yang YF, Bao SH, et al. Research advances of pancreatogenic diabetes mellitus after pancreatectomy[J]. J Abdom Surg, 2021, 34(5):396-399.
[25] Kroon VJ, Daamen LA, Tseng DJ, et al. Pancreatic exocrine insufficiency following pancreatoduodenectomy:a prospective bi-center study[J]. Pancreatology, 2022, 22(7):1020-1027.
文章导航

/